Search Results 1001-1010 of 16407 for Interindividual

1. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

   About this study. This study will determine if axatilimab in combination with standard of care posttransplant cyclophosphamide+ tacrolimus/mycophenolate ...

2. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

   Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 ...

3. The Partner II Trial: A Study of the Placement of Aortic Transcatheter Valves - Mayo Clinic

   The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery ...

4. Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation - Mayo Clinic

   This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...

5. Medical Research & Education - Mayo Clinic News Network

   How a Mayo Clinic neurologist used AI to help restore a patient's health. Just one day after undergoing brain shunt surgery at Mayo Clinic, 75-year-old ...

6. SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients - Mayo Clinic

   SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of ...

7. Medical Research & Education - Mayo Clinic News Network

   The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...

8. Survey Research Center - Why work with us?

   Find out how the Survey Research Center at Mayo Clinic helps investigators contact potential respondents, get data they want and interpret responses.

9. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

   About this study. This is an adaptive clinical trial that includes a dose escalation phase followed by a randomized controlled Phase 3 trial.

10. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...